Linking hemorrhage, angiogenesis, macrophages, and iron metabolism in atherosclerotic vascular diseases

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 37, Issue 4, 2017, Pages e33-e39

  Guo, Liang ^a   Harari, Emanuel ^a   Virmani, Renu ^a   Finn, Aloke V ^a  

^a CVPATH INSTITUTE   (United States)

Author keywords

Angiogenesis; Atherosclerosis; Hemorrhage; Iron; Macrophages

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN; IRON;

ANGIOGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLEEDING; CARDIOVASCULAR DISEASE; CELL COMMUNICATION; CLINICAL STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; HUMAN; INTRAPLAQUE HEMORRHAGE; IRON METABOLISM; MACROPHAGE; MICROVASCULATURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VASA VASORUM; ANIMAL; BLOOD VESSEL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS;

ANIMALS; ATHEROSCLEROSIS; BLOOD VESSELS; HEMORRHAGE; HUMANS; IRON; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS;

EID: 85017351891     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.117.309045     Document Type: Review

References (71)

1. Paterson JC Capillary rupture with intimal hemorrhage as a causative factor in coronary thrombosis. Arch Pathol. 1938; 25: 474-487.
2. Barger AC, Beeuwkes R III, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med. 1984; 310: 175-177. doi: 10.1056/NEJM198401193100307.
3. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005; 25: 2054-2061. doi: 10.1161/01.ATV.0000178991.71605.18.
4. Fleiner M, Kummer M, Mirlacher M, Sauter G, Cathomas G, Krapf R, Biedermann BC. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation. 2004; 110: 2843-2850. doi: 10.1161/01.CIR.0000146787.16297.E8.
5. Kockx MM, Cromheeke KM, Knaapen MW, Bosmans JM, De Meyer GR, Herman AG, Bult H. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol. 2003; 23: 440-446. doi: 10.1161/01.ATV.0000057807.28754.7F.
6. Milei J, Parodi JC, Alonso GF, Barone A, Grana D, Matturri L. Carotid rupture and intraplaque hemorrhage: immunophenotype and role of cells involved. Am Heart J. 1998; 136: 1096-1105.
7. Le Dall J, Ho-Tin-Noé B, Louedec L, Meilhac O, Roncal C, Carmeliet P, Germain S, Michel JB, Houard X. Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors. Cardiovasc Res. 2010; 85: 184-193. doi: 10.1093/cvr/cvp253.
8. Michel JB, Martin-Ventura JL, Nicoletti A, Ho-Tin-Noé B. Pathology of human plaque vulnerability: mechanisms and consequences of intraplaque haemorrhages. Atherosclerosis. 2014; 234: 311-319. doi: 10.1016/j.atherosclerosis.2014.03.020.
9. Koole D, Heyligers J, Moll FL, Pasterkamp G. Intraplaque neovascularization and hemorrhage: markers for cardiovascular risk stratification and therapeutic monitoring. J Cardiovasc Med. 2012; 13: 635-639. doi: 10.2459/JCM.0b013e3283590cd2.
10. Michel JB, Delbosc S, Ho-Tin-Noé B, Leseche G, Nicoletti A, Meilhac O, Martin-Ventura JL. From intraplaque haemorrhages to plaque vulnerability: biological consequences of intraplaque haemorrhages. J Cardiovasc Med. 2012; 13: 628-634. doi: 10.2459/JCM.0b013e328357face.
11. Matsumura M, Mintz GS, Kang SJ, et al. Intravascular ultrasound and near-infrared spectroscopic features of coronary lesions with intraplaque haemorrhage [published online ahead of print December 25, 2016]. Eur Heart J Cardiovasc Imaging. doi: 10.1093/ehjci/jew217. https://academic.oup.com/ehjcimaging/article-lookup/doi/10.1093/ehjci/jew217.
12. Takaya N, Yuan C, Chu B, Saam T, Polissar NL, Jarvik GP, Isaac C, McDonough J, Natiello C, Small R, Ferguson MS, Hatsukami TS. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation. 2005; 111: 2768-2775. doi: 10.1161/CIRCULATIONAHA.104.504167.
13. Sun J, Canton G, Balu N, Hippe DS, Xu D, Liu J, Hatsukami TS, Yuan C. Blood pressure is a major modifiable risk factor implicated in pathogenesis of intraplaque hemorrhage: an in vivo magnetic resonance imaging study. Arterioscler Thromb Vasc Biol. 2016; 36: 743-749. doi: 10.1161/ATVBAHA.115.307043.
14. Selwaness M, van den Bouwhuijsen Q, Mattace-Raso FU, Verwoert GC, Hofman A, Franco OH, Witteman JC, van der Lugt A, Vernooij MW, Wentzel JJ. Arterial stiffness is associated with carotid intraplaque hemorrhage in the general population: the Rotterdam study. Arterioscler Thromb Vasc Biol. 2014; 34: 927-932. doi: 10.1161/ATVBAHA.113.302603.
15. Ding J, Mitchell GF, Bots ML, Sigurdsson S, Harris TB, Garcia M, Eiriksdottir G, van Buchem MA, Gudnason V, Launer LJ. Carotid arterial stiffness and risk of incident cerebral microbleeds in older people: the Age, Gene/Environment Susceptibility (AGES)-Reykjavik study. Arterioscler Thromb Vasc Biol. 2015; 35: 1889-1895. doi: 10.1161/ATVBAHA.115.305451.
16. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000; 407: 249-257. doi: 10.1038/35025220.
17. Chen W, Guo Y, Walker EJ, Shen F, Jun K, Oh SP, Degos V, Lawton MT, Tihan T, Davalos D, Akassoglou K, Nelson J, Pile-Spellman J, Su H, Young WL. Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain. Arterioscler Thromb Vasc Biol. 2013; 33: 305-310. doi: 10.1161/ATVBAHA.112.300485.
18. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, Cleutjens JP, van den Akker LH, Corvol P, Wouters BG, Daemen MJ, Bijnens AP. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol. 2008; 51: 1258-1265. doi: 10.1016/j.jacc.2007.12.025.
19. Sluimer JC, Kolodgie FD, Bijnens AP, Maxfield K, Pacheco E, Kutys B, Duimel H, Frederik PM, van Hinsbergh VW, Virmani R, Daemen MJ. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol. 2009; 53: 1517-1527. doi: 10.1016/j.jacc.2008.12.056.
20. Bobryshev YV, Cherian SM, Inder SJ, Lord RS. Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation. Cardiovasc Res. 1999; 43: 1003-1017.
21. Mulligan-Kehoe MJ, Simons M. Vasa vasorum in normal and diseased arteries. Circulation. 2014; 129: 2557-2566. doi: 10.1161/CIRCULATIONAHA.113.007189.
22. Boerckel JD, Chandrasekharan UM, Waitkus MS, Tillmaand EG, Bartlett R, Dicorleto PE. Mitogen-activated protein kinase phosphatase-1 promotes neovascularization and angiogenic gene expression. Arterioscler Thromb Vasc Biol. 2014; 34: 1020-1031. doi: 10.1161/ATVBAHA.114.303403.
23. Kwon HM, Sangiorgi G, Ritman EL, Lerman A, McKenna C, Virmani R, Edwards WD, Holmes DR, Schwartz RS. Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol. 1998; 32: 2072-2079.
24. Zhu H, Zhang M, Liu Z, Xing J, Moriasi C, Dai X, Zou MH. AMP-activated protein kinase α1 in macrophages promotes collateral remodeling and arteriogenesis in mice in vivo. Arterioscler Thromb Vasc Biol. 2016; 36: 1868-1878. doi: 10.1161/ATVBAHA.116.307743.
25. Liyanage SE, Fantin A, Villacampa P, Lange CA, Denti L, Cristante E, Smith AJ, Ali RR, Luhmann UF, Bainbridge JW, Ruhrberg C. Myeloid-derived vascular endothelial growth factor and hypoxia-inducible factor are dispensable for ocular neovascularization-brief report. Arterioscler Thromb Vasc Biol. 2016; 36: 19-24. doi: 10.1161/ATVBAHA.115.306681.
26. Dunn J, Thabet S, Jo H. Flow-dependent epigenetic DNA methylation in endothelial gene expression and atherosclerosis. Arterioscler Thromb Vasc Biol. 2015; 35: 1562-1569. doi: 10.1161/ATVBAHA.115.305042.
27. Heuslein JL, Meisner JK, Li X, Song J, Vincentelli H, Leiphart RJ, Ames EG, Blackman BR, Blackman BR, Price RJ. Mechanisms of amplified arteriogenesis in collateral artery segments exposed to reversed flow direction. Arterioscler Thromb Vasc Biol. 2015; 35: 2354-2365. doi: 10.1161/ATVBAHA.115.305775.
28. Schirmer SH, Millenaar DN, Werner C, Schuh L, Degen A, Bettink SI, Lipp P, van Rooijen N, Meyer T, Böhm M, Laufs U. Exercise promotes collateral artery growth mediated by monocytic nitric oxide. Arterioscler Thromb Vasc Biol. 2015; 35: 1862-1871. doi: 10.1161/ATVBAHA.115.305806.
29. Amanso AM, Lassègue B, Joseph G, Landázuri N, Long JS, Weiss D, Taylor WR, Griendling KK. Polymerase δ-interacting protein 2 promotes post-ischemic neovascularization of the mouse hindlimb. Arterioscler Thromb Vasc Biol. 2014; 34: 1548-1555. doi: 10.1161/ATVBAHA.114.303873.
30. Rademakers T, Douma K, Hackeng TM, Post MJ, Sluimer JC, Daemen MJ, Biessen EA, Heeneman S, van Zandvoort MA Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo. Arterioscler Thromb Vasc Biol. 2013; 33: 249-256. doi: 10.1161/ATVBAHA.112.300087.
31. Choi BJ, Matsuo Y, Aoki T, Kwon TG, Prasad A, Gulati R, Lennon RJ, Lerman LO, Lerman A. Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis. Arterioscler Thromb Vasc Biol. 2014; 34: 2473-2477. doi: 10.1161/ATVBAHA.114.304445.
32. Lavoz C, Alique M, Rodrigues-Diez R, Pato J, Keri G, Mezzano S, Egido J, Ruiz-Ortega M. Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway. J Pathol. 2015; 236: 407-420. doi: 10.1002/path.4537.
33. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003; 3: 23-35. doi: 10.1038/nri978.
34. Finn AV, Nakano M, Polavarapu R, Karmali V, Saeed O, Zhao X, Yazdani S, Otsuka F, Davis T, Habib A, Narula J, Kolodgie FD, Virmani R. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J Am Coll Cardiol. 2012; 59: 166-177. doi: 10.1016/j.jacc.2011.10.852.
35. Jain RK, Finn AV, Kolodgie FD, Gold HK, Virmani R. Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization. Nat Clin Pract Cardiovasc Med. 2007; 4: 491-502. doi: 10.1038/ncpcardio0979.
36. Nagy E, Eaton JW, Jeney V, Soares MP, Varga Z, Galajda Z, Szentmiklósi J, Méhes G, Csonka T, Smith A, Vercellotti GM, Balla G, Balla J. Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler Thromb Vasc Biol. 2010; 30: 1347-1353. doi: 10.1161/ATVBAHA.110.206433.
37. Habib A, Finn AV. The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis. Front Pharmacol. 2014; 5: 195. doi: 10.3389/fphar.2014.00195.
38. Habib A, Polavarapu R, Karmali V, Guo L, Van Dam R, Cheng Q, Akahori H, Saeed O, Nakano M, Pachura K, Hong CC, Shin E, Kolodgie F, Virmani R, Finn AV. Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques. Atherosclerosis. 2015; 241: 692-700. doi: 10.1016/j.atherosclerosis.2015.06.025.
39. Boyle JJ, Harrington HA, Piper E, Elderfield K, Stark J, Landis RC, Haskard DO. Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol. 2009; 174: 1097-1108. doi: 10.2353/ajpath.2009.080431.
40. Wan X, Huo Y, Johns M, Piper E, Mason JC, Carling D, Haskard DO, Boyle JJ. 5'-AMP-activated protein kinase-activating transcription factor 1 cascade modulates human monocyte-derived macrophages to atheroprotective functions in response to heme or metformin. Arterioscler Thromb Vasc Biol. 2013; 33: 2470-2480. doi: 10.1161/ATVBAHA.113.300986.
41. Rosenberg D, Groussin L, Jullian E, Perlemoine K, Bertagna X, Bertherat J. Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann N Y Acad Sci. 2002; 968: 65-74.
42. Corsini M, Moroni E, Ravelli C, Andrés G, Grillo E, Ali IH, Brazil DP, Presta M, Mitola S. Cyclic adenosine monophosphate-response elementbinding protein mediates the proangiogenic or proinflammatory activity of gremlin. Arterioscler Thromb Vasc Biol. 2014; 34: 136-145. doi: 10.1161/ATVBAHA.113.302517.
43. Pedersen SF, Sandholt BV, Keller SH, Hansen AE, Clemmensen AE, Sillesen H, Højgaard L, Ripa RS, Kjær A. 64Cu-DOTATATE PET/MRI for detection of activated macrophages in carotid atherosclerotic plaques: studies in patients undergoing endarterectomy. Arterioscler Thromb Vasc Biol. 2015; 35: 1696-1703. doi: 10.1161/ATVBAHA.114.305067.
44. Malmberg C, Ripa RS, Johnbeck CB, Knigge U, Langer SW, Mortensen J, Oturai P, Loft A, Hag AM, Kjær A. 64Cu-DOTATATE for noninvasive assessment of atherosclerosis in large arteries and its correlation with risk factors: head-to-head comparison with 68Ga-DOTATOC in 60 patients. J Nucl Med. 2015; 56: 1895-1900. doi: 10.2967/jnumed.115.161216.
45. Evans NR, Tarkin JM, Chowdhury MM, Warburton EA, Rudd JH. PET imaging of atherosclerotic disease: advancing plaque assessment from anatomy to pathophysiology. Curr Atheroscler Rep. 2016; 18: 30. doi: 10.1007/s11883-016-0584-3.
46. Armani C, Catalani E, Balbarini A, Bagnoli P, Cervia D. Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages. J Leukoc Biol. 2007; 81: 845-855. doi: 10.1189/jlb.0606417.
47. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, Johnström P, Davenport AP, Kirkpatrick PJ, Arch BN, Pickard JD, Weissberg PL. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002; 105: 2708-2711.
48. Gadde S, Rayner KJ. Nanomedicine meets microRNA: current advances in RNA-based nanotherapies for atherosclerosis. Arterioscler Thromb Vasc Biol. 2016; 36: e73-e79. doi: 10.1161/ATVBAHA.116.307481.
49. Fisher EA Regression of atherosclerosis: the journey from the liver to the plaque and back. Arterioscler Thromb Vasc Biol. 2016; 36: 226-235. doi: 10.1161/ATVBAHA.115.301926.
50. Cui J, Kessinger CW, McCarthy JR, Sosnovik DE, Libby P, Thadhani RI, Jaffer FA. In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula. Arterioscler Thromb Vasc Biol. 2015; 35: 189-196. doi: 10.1161/ATVBAHA.114.304483.
51. Møller HJ. Soluble CD163. Scand J Clin Lab Invest. 2012; 72: 1-13. doi: 10.3109/00365513.2011.626868.
52. Akahori H, Karmali V, Polavarapu R, et al. CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury. Nat Commun. 2015; 6: 7792. doi: 10.1038/ncomms8792.
53. Aristoteli LP, Møller HJ, Bailey B, Moestrup SK, Kritharides L. The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis. Atherosclerosis. 2006; 184: 342-347. doi: 10.1016/j.atherosclerosis.2005.05.004.
54. Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, Rosenberg ES, Williams KC, Grinspoon S. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis. 2011; 204: 1227-1236. doi: 10.1093/infdis/jir520.
55. Shaked I, Hanna DB, Gleißner C, et al. Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection. Arterioscler Thromb Vasc Biol. 2014; 34: 1085-1092. doi: 10.1161/ATVBAHA.113.303153.
56. Verhagen SN, Visseren FL. Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis. 2011; 214: 3-10. doi: 10.1016/j.atherosclerosis.2010.05.034.
57. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009; 29: 313-326. doi: 10.1089/jir.2008.0027.
58. Manka D, Chatterjee TK, Stoll LL, Basford JE, Konaniah ES, Srinivasan R, Bogdanov VY, Tang Y, Blomkalns AL, Hui DY, Weintraub NL. Transplanted perivascular adipose tissue accelerates injury-induced neointimal hyperplasia: role of monocyte chemoattractant protein-1. Arterioscler Thromb Vasc Biol. 2014; 34: 1723-1730. doi: 10.1161/ATVBAHA.114.303983.
59. Eirin A, Zhu XY, Li Z, Ebrahimi B, Zhang X, Tang H, Korsmo MJ, Chade AR, Grande JP, Ward CJ, Simari RD, Lerman A, Textor SC, Lerman LO. Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis. Arterioscler Thromb Vasc Biol. 2013; 33: 1006-1013. doi: 10.1161/ATVBAHA.113.301164.
60. Fung E, Helisch A. Macrophages in collateral arteriogenesis. Front Physiol. 2012; 3: 353. doi: 10.3389/fphys.2012.00353.
61. Bruce AC, Kelly-Goss MR, Heuslein JL, Meisner JK, Price RJ, Peirce SM. Monocytes are recruited from venules during arteriogenesis in the murine spinotrapezius ligation model. Arterioscler Thromb Vasc Biol. 2014; 34: 2012-2022. doi: 10.1161/ATVBAHA.114.303399.
62. Sullivan JL Iron and the sex difference in heart disease risk. Lancet. 1981; 1: 1293-1294.
63. Boytard L, Spear R, Chinetti-Gbaguidi G, Acosta-Martin AE, Vanhoutte J, Lamblin N, Staels B, Amouyel P, Haulon S, Pinet F. Role of proinflammatory CD68(+) mannose receptor(-) macrophages in peroxiredoxin-1 expression and in abdominal aortic aneurysms in humans. Arterioscler Thromb Vasc Biol. 2013; 33: 431-438. doi: 10.1161/ATVBAHA.112.300663.
64. Saeed O, Otsuka F, Polavarapu R, et al. Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32: 299-307. doi: 10.1161/ATVBAHA.111.240101.
65. Li JJ, Meng X, Si HP, Zhang C, Lv HX, Zhao YX, Yang JM, Dong M, Zhang K, Liu SX, Zhao XQ, Gao F, Liu XL, Cui TX, Zhang Y. Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosis. Arterioscler Thromb Vasc Biol. 2012; 32: 1158-1166. doi: 10.1161/ATVBAHA.112.246108.
66. Sawada H, Hao H, Naito Y, Oboshi M, Hirotani S, Mitsuno M, Miyamoto Y, Hirota S, Masuyama T. Aortic iron overload with oxidative stress and inflammation in human and murine abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 2015; 35: 1507-1514. doi: 10.1161/ATVBAHA.115.305586.
67. Zhang Y, Guallar E, Qiao Y, Wasserman BA. Is carotid intima-media thickness as predictive as other noninvasive techniques for the detection of coronary artery disease? Arterioscler Thromb Vasc Biol. 2014; 34: 1341-1345. doi: 10.1161/ATVBAHA.113.302075.
68. Prats-Puig A, Moreno M, Carreras-Badosa G, Bassols J, Ricart W, López-Bermejo A, Fernández-Real JM. Serum ferritin relates to carotid intima-media thickness in offspring of fathers with higher serum ferritin levels. Arterioscler Thromb Vasc Biol. 2016; 36: 174-180. doi: 10.1161/ATVBAHA.115.306396.
69. Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011; 117: 4425-4433. doi: 10.1182/blood-2011-01-258467.
70. Galesloot TE, Holewijn S, Kiemeney LA, de Graaf J, Vermeulen SH, Swinkels DW. Serum hepcidin is associated with presence of plaque in postmenopausal women of a general population. Arterioscler Thromb Vasc Biol. 2014; 34: 446-456. doi: 10.1161/ATVBAHA.113.302381.
71. Bories G, Colin S, Vanhoutte J, Derudas B, Copin C, Fanchon M, Daoudi M, Belloy L, Haulon S, Zawadzki C, Jude B, Staels B, Chinetti-Gbaguidi G. Liver X receptor activation stimulates iron export in human alternative macrophages. Circ Res. 2013; 113: 1196-1205. doi: 10.1161/CIRCRESAHA.113.301656.